AXGN vs BMRN · rev $131.2M vs P/E 40, rev $1.76B
Axogen Inc (AXGN) versus Biomarin Pharmaceutical Inc (BMRN) — a side-by-side from cached financials, not a winner call.
Axogen Inc (AXGN) is a medical devices company listed on US.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Latest reported AXGN revenue for 2026-06-30 was $131.2M. Net income was -$21.1M. AXGN currently screens at market cap $497.8M.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
AXGN currently screens at market cap $497.8M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Not investment advice. Open the AXGN and BMRN stock pages for the full models.
Not investment advice.